Detalhe da pesquisa
1.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495881
2.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37827694
3.
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754981
4.
Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies.
Rheumatology (Oxford)
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754125
5.
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis.
Rheumatology (Oxford)
; 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38218744
6.
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).
J Rheumatol
; 51(5): 479-487, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359937
7.
Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations.
Clin Exp Rheumatol
; 42(3): 696-701, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38019168
8.
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
Ann Rheum Dis
; 82(7): 927-936, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37085289
9.
Genetics of osteonecrosis in children and adults with systemic lupus erythematosus.
Rheumatology (Oxford)
; 62(9): 3205-3212, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36651668
10.
Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE.
Rheumatology (Oxford)
; 62(2): 617-628, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35789257
11.
Incidence and predictors of demyelinating disease in spondyloarthritis: data from a longitudinal cohort study.
Rheumatology (Oxford)
; 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792508
12.
Isolated axial disease in psoriatic arthritis and ankylosing spondylitis with psoriasis.
Ann Rheum Dis
; 81(12): 1678-1684, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973805
13.
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 81(11): 1541-1548, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944946
14.
Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Ann Rheum Dis
; 81(3): 370-378, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34911705
15.
Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
Ann Rheum Dis
; 81(8): 1143-1150, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338033
16.
Assessment of the Toronto Psoriatic Arthritis Screen 2 as a Screening Tool for Psoriasis.
J Cutan Med Surg
; 26(3): 237-242, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34841919
17.
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE.
Ann Rheum Dis
; 80(6): 767-774, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33452003
18.
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis.
Ann Rheum Dis
; 80(11): 1429-1435, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049856
19.
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.
Ann Rheum Dis
; 80(6): 775-781, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33568386
20.
Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis.
Rheumatology (Oxford)
; 60(1): 73-80, 2021 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140092